Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
May 28, 2025 - Alcon announced the FDA approval of Tryptyr (acoltremon), for the treatment of the signs and symptoms of dry eye disease (DED).
Download PDF
Return to publications
